This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Elezi, S. Articles by Kastrati, A. Search for Related Content PubMed PubMed Citation Articles by Elezi, S. Articles by Kastrati, A. Related Collections Related Article

Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement

Results From a Large Cohort of Patients Treated With Sirolimus- or Paclitaxel-Eluting Stents

Shpend Elezi, MD^_*, Alban Dibra, MD^_*, Julinda Mehilli, MD^_*, Jürgen Pache, MD^_*, Rainer Wessely, MD^_*, Albert Schömig, MD and Adnan Kastrati, MD^_*,_*,1

^_* Deutsches Herzzentrum, Technische Universität, Munich, Germany
First Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany.

View larger version (35K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Late lumen loss in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents.

View larger version (32K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Target lesion revascularization rate in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents. Note that a significant difference between the 2 drug-eluting stents is only seen among patients in the lower tertile.